Novartis, Takeda, BMS, Bayer Implement Large-Scale Job Cuts
Mostly Targeting Overseas R&D Staff… Bayer Korea Faces Position Changes
Global pharmaceutical companies are undergoing large-scale 카지노 정팔, including significant workforce reductions, to cut operational costs. However, the impact has not yet extended to their Korean branches. Bayer Korea, influenced by its headquarters, may see some position changes.
According to industry sources on July 24th, major global pharmaceutical companies such as Novartis, Takeda Pharmaceutical, Bristol-Myers Squibb (BMS), and Bayer are undertaking 카지노 정팔 efforts involving workforce reductions and organizational changes
Novartis announced the closure of its basic R&D department in the U.S. to streamline its research and development processes. This move led to the layoff of 29 employees from the department, with plans to cut 680 positions in the development sector, including 440 at its headquarters in Switzerland and 240 in the U.S. branch.
Takeda Pharmaceutical aims to save approximately 6 million by reorganizing its structure by March 2025. In the first quarter of this year, Takeda's sales amounted to .7 billion, a decrease of 3 million from the previous quarter's .1 billion. Industry experts attribute Takeda Pharmaceutical's 카지노 정팔 to the loss of exclusivity for its Japanese hypertension drug, Azilva, and the American ADHD treatment, Vyvanse, leading to decreased sales. The company is reducing its workforce to mitigate losses from declining operating profits. The savings will be reinvested in high-potential, marketable products, including the dengue fever vaccine, Qdenga, currently in development.
Bristol-Myers Squibb (BMS) is set to cut costs by .9 billion by the end of 2025. Facing an operating loss of .9 billion in the first quarter, the company has opted for 카지노 정팔 as a means to curb ongoing losses. This 카지노 정팔 will involve downsizing its experimental drug pipeline and consolidating offices and laboratories.
Bayer's global headquarters laid off 1,500 employees in the first quarter of this year due to the economic downturn. Consequently, Bayer Korea is also expected to see some position changes. A representative from Bayer Korea stated, "We are undergoing 카지노 정팔 to operate the organization more efficiently and agilely. We will maintain continuous communication with those affected by the position changes to ensure successful organizational management."
However, other companies, aside from Bayer Korea, appear to be unaffected. The ongoing 카지노 정팔 focuses on reducing overseas R&D staff, with no impact on domestic operations. Industry insiders confirmed, "There has been no information relayed to local subsidiaries regarding overseas R&D staff reductions, such as those in Boston. Therefore, there is currently no impact on domestic companies."